NEOCHEMNSENEOCHEM BIO SOLUTIONS LTDHighNeutral
Announced Tue, 27 Oct, 2026 · 18:53 IST

H1 revenue rises 41% but operating cash flow is negative

Revenue Growth 20pctEbitda Margin CompressionExceptional ItemNegative Operating CashflowResults View source PDFExplain this filing

NEOCHEM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction

Awaiting price reaction for this filing.

AI summary

For the half year ended September 30, 2026, revenue from operations rose 41.5% to Rs 6,486.78 lakh from Rs 4,583.16 lakh. Profit after tax was Rs 654.28 lakh, up 19.3%, after an exceptional item of Rs 61.89 lakh. Operating cash flow was negative Rs 105.25 lakh, cash was Rs 18.49 lakh and borrowings reached Rs 3,308.13 lakh. The auditor raised no material concerns. Part of a July cyber fraud loss was recovered; the rest is still being recovered.

Likely market impact

Strong earnings growth is positive, but weak cash flow, higher debt and the pending fraud recovery could weigh on the stock.